Testing effectiveness (Phase 2)Study completedNCT01161160
What this trial is testing
Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old
Who this might be right for
Influenza
GlaxoSmithKline 209